Planmed Oy, a leading provider of advanced medical imaging solutions, is proud to announce that its Planmed Clarity+™ mammography product line has successfully received CE MDR (Medical Device Regulation) certification and is now ready for the European market.
This milestone reflects Planmed’s commitment to delivering safe, effective, and innovative imaging technologies that meet the highest standards of quality and regulatory compliance in the European Union.
“With over 30 years of experience in imaging development, it’s fair to say that it’s in our DNA, and we are strongly committed to improving the early detection of breast cancer. Planmed Clarity+™ is the newest addition to the renowned Planmed mammography family and represents the third generation of our digital mammography systems,” states Jan Moed, Managing Director of Planmed Oy.
“With Planmed Clarity+, we introduce advanced features, such as contrast-enhanced mammography (CEM), to support the evolving needs of breast imaging and diagnostics. Our mission is to provide solutions to confidently guide the clinical pathway from screening to diagnostics,” continues Moed.
Advancing mammography with Planmed Clarity+ product line
The Planmed Clarity+ product line is designed to provide superior image quality, optimized workflow, and patient comfort in mammography. With advanced features such as:
Planmed Clarity+ empowers clinicians to detect breast cancer earlier and more reliably, contributing to improved patient outcomes.
Commitment to quality and innovation
“Achieving CE MDR certification for the Planmed Clarity+ product line in such a short period of time is a significant achievement for our team and a testament to our dedication to innovation and patient safety,” says Satu Seppälä, Sales and Marketing Director at Planmed. “We are proud to provide healthcare providers across Europe with cutting-edge mammography solutions that meet the highest regulatory standards.”